You are here: Home » News-CM » Companies » Results
Business Standard

Shukra Pharmaceuticals reports standalone nil net profit/loss in the June 2019 quarter

Capital Market 

Sales decline 0.95% to Rs 1.04 crore

Shukra Pharmaceuticals reported no net profit/loss in the quarter ended June 2019 as against net profit of Rs 0.04 crore during the previous quarter ended June 2018. Sales declined 0.95% to Rs 1.04 crore in the quarter ended June 2019 as against Rs 1.05 crore during the previous quarter ended June 2018. ParticularsQuarter EndedJun. 2019Jun. 2018% Var.Sales1.041.05 -1 OPM %14.4233.33 -PBDT0.150.38 -61 PBT00.20 -100 NP00.04 -100

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, August 19 2019. 12:26 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU